227 related articles for article (PubMed ID: 21719208)
1. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
2. [Expression of enhancer of zesle homolog 2 and phosphatase and tension homolog and its clinicopathological significance in benign and malignant lesion of gallbladder].
Liu DC; Yang ZL; Yang LP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):618-22. PubMed ID: 18667776
[TBL] [Abstract][Full Text] [Related]
3. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
[TBL] [Abstract][Full Text] [Related]
5. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
7. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
Yang L; Lan S; Liu J; Yang Z
Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Yang ZL; Liu DC
Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Lv F; Yang ZL; Miao XY
Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma.
Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL
Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
13. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
14. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Huqun ; Ishikawa R; Zhang J; Miyazawa H; Goto Y; Shimizu Y; Hagiwara K; Koyama N
Cancer; 2012 Mar; 118(6):1599-606. PubMed ID: 21837672
[TBL] [Abstract][Full Text] [Related]
15. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
Yang L; Guo T; Jiang S; Yang Z
Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
[TBL] [Abstract][Full Text] [Related]
16. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
18. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Diagn Cytopathol; 2013 Mar; 41(3):199-205. PubMed ID: 21964981
[TBL] [Abstract][Full Text] [Related]
19. BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.
Yang Z; Liu F; Yang ZL
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):275-82. PubMed ID: 26200836
[TBL] [Abstract][Full Text] [Related]
20. PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.
Zou Q; Yang L; Yang Z; Huang J; Fu X
Biomed Res Int; 2013; 2013():648420. PubMed ID: 23984394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]